Intervention study of Istradefylline for the Treatment of Abnormal Posture in Patients with Parkinson's Disease
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-UMIN000026492
- Lead Sponsor
- Osaka Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 31
Not provided
1) A score of <= 20 on the mini-mental state examination (mmse) 2) patients with abnormal posture which is not derived from parkinson's disease (e.g. compressed fracture of backbone, fracture of the pelvis, drug-induced abnormal posture) 3) patients with impact for evaluation by such treatment as deep brain stimulation transcranial magnetic stimulation or electroconvulsive therapy et cetera. 4) current use or plan to administer levodopa/carbidopa intestinal gel 5) ongoing treatment with botulinus toxin or passed treatment with botulinus toxin within 6 months 6) ongoing treatment with istradefylline or passed treatment with istradefylline within 1 year 7) moderate to severe hepatic disorder or current treatment with a strong inhibitor of cyp3a4 8) lactating, pregnant, or possibly pregnant women 9) other conditions judged by the investigator or subinvestigator to be unsuitable for participation in the research
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method